Insmed Incorporated (INSM): Billionaire Stan Druckenmiller Trims Stake

Insmed Incorporated (NASDAQ:INSM) is one of Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential.

Insmed Incorporated (NASDAQ:INSM) first appeared in the 13F portfolio of Duquesne Capital back in the second quarter of 2020. This position comprised 1.2 million shares and was sold off by the next quarter. A new position was opened in the stock in the second quarter of 2024. This holding consisted of just 20,000 shares. However, the fund upped this to over 2.4 million shares by the third quarter of 2025. Filings for the fourth quarter of 2025 reveal that the fund owned nearly 1.5 million shares in the firm, down 38% compared to the previous quarter.

READ ALSO: 10 Best Stocks to Invest In According to Billionaire Steve Cohen.

Analyst Says Dell Technologies (DELL) is a Cheap AI Stock Amid Major ‘Disruption’ - ‘I’m Not Kidding’

Hedge fund interest in Insmed Incorporated (NASDAQ:INSM) stock is primarily due to the successful transitioning of the firm from a clinical-stage biotech into a commercial powerhouse with a dominant lead in rare lung diseases. The commercial performance of Brinsupri, the first-ever approved treatment for non-cystic fibrosis bronchiectasis, is the most important. In its first full quarter of launch (Q4 2025), Brinsupri generated $144.6 million, shattering analyst expectations. CEO Will Lewis noted that Insmed essentially owns this entire disease category with no immediate competition. Hedge funds are pricing in peak sales of $5 billion+, with 2026 guidance already set at a minimum of $1 billion.

While we acknowledge the risk and potential of INSM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than INSM and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 12 Best Stocks to Buy According to Billionaire David Abrams and 15 Best Stocks to Buy According to Billionaire Seth Klarman.

Disclosure: None. Follow Insider Monkey on Google News.